Abstract
The rapid inactivation of 5-HT makes it possible to give large doses to animals over many weeks ; moreover tolerance rapidly develops and near lethal doses can be quickly increased. Hedinger and Veraguth (1962) for example, using rats, started with daily intraperitoneal doses of 1 to 15 mg base/kg and were able to increase the dose to over 500 mg base/kg in 20 days. Similarly with guinea-pigs, starting with a dose of 40 mg base/kg i.p., the dose could be doubled every 5 days until 320 mg base/kg was being given. However when large doses are given, whether singly or repeatedly, morphological changes develop in many organs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Angrist, A., M. Oka, and K. Nakao: Failure to produce right-sided valve lesions by intra-hepatic pellets of 5-hydroxytryptophan. Fed. Proc. 21, 95 (1962).
Archer, R. K.: Eosinophil leucocytes and their reactions to histamine and 5-hydroxytrypt-amine. J. Path. Bact. 78, 95–103 (1959).
Asboe-Hansen, G., and O. Wegelius: Serotonin and connective tissue. Nature (Lond.) 178, 262 (1956).
Ballerini, G., e T. Cantelli: Piastrinosi sperimentale da 5-idrossitriptamma. Boll. Soc. ital. Ematol. 3, 405–408 (1955).
Baumgartner, H. R., A. Studer u. K. Reber: Über Methoden zur Erzeugung experimenteller Thrombosen am Kaninchenohr und die Bedeutung von 5-Hydroxytryptamin bei deren Entstehung. Thrombos. Diathes. haemorrh. (Stuttg.) 9, 48–511 (1963).
Blackmax, J. G., D. S. Campion, and F. M. Fastier: Mechanism of action of reserpine in producing gastric haemorrhage and erosion in the mouse. Brit. J. Pharmacol. 14, 112–116 (1959).
Boccabella, A. V., E. D. Salgado, and E.A. Alger: Testicular function and histology following serotonin administration. Endocrinology 71, 827–837 (1962).
Boseila, A.-W. A.: Influence of heparin and serotonin on basophil leucocytes of rabbit blood. Experientia (Basel) 15, 343–344 (1959).
Brosman, S. A., P. F. Bradford, and F. W. Hughes: Modification of renal lesions produced by 5-hydroxytryptamine (serotonin). Amer. J. Clin. Path. 32, 457–464 (1959).
Carlier, J., G. Lejeune-Ledant et Ch. Keil: 5-Hydroxytryptamine, lésions pulmonaires et pression artérielle pulmonaire. Med. exp. (Basel) 1, 72–77 (1959).
Cenacchi, G. C., E. Bergami, D. Cavazzoni e L. Rosa: Effetto eosinopenico délia 5-ossitript-amina. Folia allerg. (Roma) 6, 14–24 (1959).
Davidson, J., A. Sjoerdsma, L. N. Loomis, and S. Udenfriend: Studies with the serotonin precursor, 5-hydroxytryptophan, in experimental animals and man. J. clin. Invest. 36, 1594–1599 (1957).
Eder, M., u. A. Schauer: Morphologische und experimentelle Untersuchungen zur Fibro-sierung beim Carcinoid. Beitr. path. Anat. 121, 375–405 (1959).
Erspamer, V.: Pharmocology of indolealkylamines. Pharmacol. Rev. 6, 425–487 (1954a).
Erspamer, V.: Observations on the fate of oral 4-HTP in man. Experientia (Basel) 17, 351–352 (1961a).
Erspamer, V.: Recent research in the field of 5-hydroxytryptamine and related indolealkylamines. Fortschr. Arzneimittelforsch. 3, 151–367 (1961b).
Feldberg, W., and A.N. Smith: Release of histamine by tryptamine and 5-hydroxytryptamine. Brit. J. Pharmacol. 8, 406–411 (1953).
Ferrata. A., e G. A. Cappelletti: Sulla trombocitosi da serotonina. Haematologica 44, 501–512 (1959).
Fiore-Donati, L. and V. Erspamer: Studies on the nephrotoxicity of 5-hydroxytryptamine (enteramine) in the rat. Amer. J. Path. 33, 895–917 (1957).
Gottlieb, L. S., S. A. Broitman, J. J. Vitale, and N. Zamcheck: Failure of endogenous serotonin to produce lesions of the carcinoid syndrome. Studies in mouse mastocytoma. Arch. Path. 69, 77–81 (1960).
Haverback, B. J. and D. F. Bogdanski: Gastric mucosal erosion in the rat following administration of the serotonin precursor, 5-hydroxytryptophan. Proc. Soc. exp. Biol. (N.Y.) 95, 392–393 (1957).
Hedinger, C.: Hodenveränderungen bei Ratten und Meerschweinchen nach Serotonin-injektionen. Path, et Microbiol. (Basel) 26, 325–329 (1963).
Hedinger, C., u. H. Langemann: Ausgesprochene Thrombocytose bei Ratten unter Behandlung mit 5-Oxytryptamin. Schweiz. med. Wschr. 85, 368–370 (1955a).
Hedinger, C., u. H. Langemann: Nierenschädigungen mit Rindennekrosen bei Ratten unter Behandlung mit 5-Oxy-tryptamine. Schweiz. med. Wschr. 85, 541–544 (1955b).
Hedinger, C., u. F. Veraguth: Magengeschwüre bei Ratten unter Behandlung mit 5-Hydroxytryptamin. Schweiz. med. Wschr. 87, 1175–1176 (1957).
Hedinger, C., u. F. Veraguth: Magengeschwüre bei Ratten und Meerschweinchen nach intraperitonealer Injektion von 5-Hydroxytryptamin (Serotonin). Z. ges. exp. Med. 136, 64–77 (1962).
Honour, A. J., and J. R. A. Mitchell: Platelet clumping in vivo. Nature (Lond.) 197, 1019–1020 (1963).
Huser, H. J., C. Sandri u. C. Hedinger: Thrombozytose bei Meerschweinchen unter massiver Behandlung mit 5-Hydroxytryptamin (Serotonin). Klin. Wschr. 37, 660–662 (1959).
Jasmin, G., and P. Bois: Effect of various agents on the development of kidney infarcts in rats treated with serotonin. Lab. Invest. 9, 503–515 (1960).
Kim, K. S., and P. A. Shore: Mechanism of action of reserpine and insulin on gastric amines and gastric secretion and the effect of monoamine oxidase inhibition. J. Pharmacol. exp. Ther. 141, 321–325 (1963).
Kwaan, H. C., R. Lo, and A. J. S. Mcfadzean: On the lysis of thrombi experimentally produced within veins. Brit. J. Haemat. 4, 51–62 (1958).
LA Barre, J.: A propos de la pathogénèse de l’ulcère gastrique post réserpinique. C. R. Soc. Biol. (Paris) 153, 364–366 (1959).
Langemann, H., u. J. Kägi: Oxytryptamin-und Oxyindolessigsäurebestimmungen bei einem Fall von Carcinoidsyndrom, nebst einigen anderen Untersuchungen über Oxytryptamin. Klin. Wschr. 34, 237–241 (1956).
Leusen, L., E. Lacroix, and G. Demeester: Influence of iproniazid on formation of gastric ulcères by reserpine in the rat. Experientia (Basel) 15, 73 (1959).
Levis, S., et J. Beersaerts: E’tude de l’activité de la chlorbenzoxamine dans quelques types d’ulcères expérimentaux. Pharmacodyn. 126, 359–364 (1960).
Lindsay, D., E. Poulson, and J. M. Robson: The effect of 5-HT on pregnancy. J. Endocr. 26, 85–96 (1963).
Macdonald, R. A.: Pathogenesis of lesions induced by serotonin: nutritional, vascular, auto-radiographic and comparative studies using epinephrine. Amer. J. Path. 35, 297–313 (1959).
Macdonald, R. A., and S. L. Robbins: Dermal fibrosis following subcutaneous injections of serotonin crea-tinine sulphate. Proc. Soc. exp. Biol. (N.Y.) 97, 334–337 (1958b)., and G. K. MALLORY: Morphologic effects of serotonin (5-hydroxytryptamine). Arch. Path. 65, 369-377 (1958a).
Macdonald, R. A.: R. Schmid, T. R. Hakala, and G. K. Mallory: Effect of serotonin upon liver cells of young rats. Proc. Soc. exp. Biol. (N.Y.) 101, 83–86 (1959).
Meites, J., C. S. Nicoll, and P. K. Talwalker: Effect of reserpine and serotonin on milk secretion and mammary growth in the rat. Proc. Soc. exp. Biol. (N.Y.) 101, 563–365 (1959).
Meites, J., P. K. Talwalker, and C. S. Nicoll: Induction of mammary growth and lactation in rabbits with epinephrine, acetylcholine and serotonin. Proc. Soc. exp. Biol (N.Y.) 104, 192–194 (1960).
Morlunghi, C. e P. Romeo: Effetti della somministrazione cronica della 5-idrossitriptamina (serotonina) sulla coniglia gravida. Arch. Ostet. Ginec. 66, 155–173 (1961).
Ntkodijevic, B., and T. Trajkov: Mechanism of ulcerogenic action of 5-hydroxytryptamine in rat’s stomach. Biochem. Pharmacol. 8, 169 (1961).
Ntkodijevic, B., and S. Yanov: The influence of thenalidine on reserpine-and serotonin-induced gastric ulcers in rats. Experientia (Basel) 16, 464–465 (1960).
Owens, F. J., and G. M. C. Masson: Effects of amine liberators on gastric secretions in the rat. J. Lab. clin. Med. 53, 932–933 (1958).
Page, E. W., and M. B. Glendening: Production of renal cortical necrosis with serotonin (5-hydroxytryptamine). Amer. J. Med. 19, 285 (1955).
Poulson, E., M. Botros, and J. M. Robson: Effect of 5-hydroxytryptamine and iproniazid on pregnancy. Science 181, 1101–1102 (1960).
Poulson, E., J. M. Robson. and F. M. Sullivan: Teratogenic effect of 5-HT in mice. Science 141, 717–718 (1963b).
Reddy. D. V., F. H. Adams, and C. Baird: Teratogenic effects of serotonin. J. Pediat. 63, 394–401 (1963).
Robertson, J. I. S., W. S. Peart, and T. M. Andrews: The mechanism of facial flushes in the carcinoid syndrome. Quart. J. Med. 31, 103–123 (1962).
Robson, J. M., and M. Botros: The effect of 5-hydroxytryptamine and of monoamine oxidase inhibitors on sexual maturity. J. Endocr. 22, 165–175 (1961).
Robson, J. M., and F. M. Sullivan: Mechanism of lethal action of 5-HT on the foetus. J. Endocr. 25, 553–554 (1963).
Rosa, L., G. C. Cenacchi et G. Bergami: Les variations numériques des éosinophiles circulants après injection d’antigène, d’histamine ou de 5-hvdroxvtrvptamine. Acta allerg. (Kbh.) 12, 427–431 (1958).
Rossi, P., M. Stevenson, P. Khaksar. and S. Bellet: Coronary arteriosclerosis induced in young dogs bv prolonged intra-aortic infusion of serotonin. Circulat. Res. 9. 436–440 (1961).
Rossi, P., and L. Zamboni: Pulmonary arteriosclerosis due to serotonin. Nature (Lond.) 181, 1216–1217 (1958).
Salgado, E. and D. M. Green. Renal necrosis induced in rats by serotonin. Amer. J. Physiol. 183, 657 (1955).
Schauer, A., u. M. Eder: Der Fibrosierungsvorgano-beim Darmcarcinoid. Klin. Wschr. 37, 880–881 (1959).
Scherbel, A. L., R. L. Mckittrick, and W. A. Hawk: Lesions in rats caused by serotonin and histamine before and after amine oxidase inactivation and serotonin inhibition. J. clin. Invest. 39, 1025–1026 (1960).
Serra, U. e K. Bruni: Comportamento delle piastrine e degli eosinofili circulante dopo somministrazione di 5-ossitriptamina in dose unica nel ratto. Folia endocr. (Roma) 10, 657–664 (1957).
Steger, C.: Contributo sperimentale alla conoscenza dei rapporti esisteni tra carcinoidi intestinale e lesioni del cuore destro. Arch. ital. Chir. 84, 202 (1958).
Steiner, F. A., u. C. Hedinger: Thromtozytose und Eosinopenie bei Ratten nach einmaliger 5-Oxytryptamininjektion. Experientia (Basel) 12, 109–111 (1956).
Steiner, F. A., R. E. Siebenmann, C. Sandri u. C. Hedinger: Thrombozytose und Eosinophilie bei Adrenalektomierten Ratten nach einmaliger 5-Hydroxytryptamininjection. Experientia (Basel) 13, 500–502 (1957).
Waugh, D., and M. J. Pearl: Serotonin-induced acute nephrosis and renal cortical necrosis in rats. Amer. J. Path. 36, 431–455 (1960).
Wilhelmi. G.: Über die ulcerogene Wirkung von 5-Hvdroxytrvptamine am Rattenmagen und deren Beeinflussung durch verschiedene Pharmaca. Helv. physiol. acta. 15, C., 83–84 (1957).
Wilhelmi. G., u. W. Schindler: Über die gastrotrope Wirkung von 5-Hydroxytryptamine (HTA), seiner Vorstufen und der entsprechenden Isomeren bei der Ratte. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 236 49–51 (1959).
Zbinden, G., A. Pletscher u. A. Studer: Beeinflussung experimenteller Magengeschwüre durch Reserpin, Tetrabenazin und Iproniazid (Marsilid). Schweiz. med. Wschr. 89, 289–291 (1959).
Zbinden, G., A. Pletscher u. A. Studer: Bluteosinophile und Thrombocyten bei Hemmung der Monoaminoxydase und weiteren Einwirkungen auf den Katecholamin-und 5-Hvdroxytrvptamin-Stoffwechsel. Schweiz. med. Wschr. 88, 1067–1070 (1958).
Editor information
Rights and permissions
Copyright information
© 1966 Springer-Verlag, Berlin · Heidelberg
About this chapter
Cite this chapter
Stacey, R.S. (1966). Morphological changes caused by injections of 5-HT in animals and man. In: Erspamer, V. (eds) 5-Hydroxytryptamine and Related Indolealkylamines. Handbook of Experimental Pharmacology/Handbuch der experimentellen Pharmakologie, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85467-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-85467-5_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85469-9
Online ISBN: 978-3-642-85467-5
eBook Packages: Springer Book Archive